Vimarsana
Biggest News Aggregation in the World

Page 2 - Expanded Access Protocol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expanded Access Protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expanded Access Protocol Today - Breaking & Trending Today

National Institutes of Health Awards $45.1 Million NINDS Grant for CNM-Au8 Study in ALS - Vimarsana News

National Institutes of Health Awards $45.1 Million NINDS Grant for CNM-Au8 Study in ALS

05.10.2023 - Funding to Support Research and Expanded Access of Investigational Drug in ALSSALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) - Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia ... Seite 1

Geron Announces U.S. Expanded Access Protocol for Imetelstat in Lower Risk MDS - Vimarsana News

Geron Announces U.S. Expanded Access Protocol for Imetelstat in Lower Risk MDS

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that an Expanded Access Protocol (EAP) is available for imetelstat, the Company’s first-in-class telomerase inhibitor. As allowed under the U.S. Food...

NanOlogy Presents Clinical Research at 2023 DDW and ASCO Involving its Large Surface Area Microparti - Vimarsana News

NanOlogy Presents Clinical Research at 2023 DDW and ASCO Involving its Large Surface Area Microparti

FORT WORTH, Texas--(BUSINESS WIRE)--NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle (LSAM) investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.The DDW poster entitled “Intracystic Injecti...

Sarah Langs' battle with ALS highlighted by ESPN, MLB teams, and more - Vimarsana News

Sarah Langs' battle with ALS highlighted by ESPN, MLB teams, and more

Sarah Langs, a researcher, writer, and on-air voice for MLB Network and MLB.com, has been battling ALS, and is being honored across baseball.

Mesoblast Limited (NASDAQ:MESO) Q2 2023 Earnings Call Transcript - Vimarsana News

Mesoblast Limited (NASDAQ:MESO) Q2 2023 Earnings Call Transcript

Silviu Itescu: Thank you very much, operator. Good afternoon, good morning to everybody.